The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
 
Laurent Mhanna
No Relationships to Disclose
 
Julie Milia
No Relationships to Disclose
 
Amellie Lusque
No Relationships to Disclose
 
Sebastien Couraud
No Relationships to Disclose
 
Celine Mascaux
No Relationships to Disclose
 
Remi Veillon
No Relationships to Disclose
 
Martin Frueh
No Relationships to Disclose
 
Denis Moro-Sibilot
No Relationships to Disclose
 
Mickaël Lattuca-Truc
No Relationships to Disclose
 
Pascale Tomasini
No Relationships to Disclose
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Merck Serono; Novartis; Pfizer; Pierre Fabre; Pierre Fabre
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; Merck Serono; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Alexander E. Drilon
Honoraria - AstraZeneca; Blueprint Medicines; Exelixis; Genentech/Roche; Ignyta; Loxo
Consulting or Advisory Role - ARIAD
Research Funding - Foundation Medicine
 
Oliver Gautschi
No Relationships to Disclose
 
Julien Mazieres
No Relationships to Disclose